Ruben Gonzales, Ccrp
About Ruben Gonzales, Ccrp
Ruben Gonzales is a Global Clinical Trial Manager with extensive experience in clinical operations and regulatory compliance within the pharmaceutical and healthcare industries. He has worked for several organizations, including CytomX Therapeutics and Acerta Pharma, contributing to various clinical research projects.
Work at CytomX Therapeutics
Ruben Gonzales serves as the Global Clinical Trial Manager at CytomX Therapeutics, a position he has held since 2021. His role involves overseeing global clinical trials, ensuring compliance with regulatory standards, and managing clinical operations. His experience in this position builds on his extensive background in clinical research and trial management.
Previous Experience at Pliant Therapeutics
Prior to his current role, Gonzales worked at Pliant Therapeutics for one year in Clinical Operations from 2020 to 2021. During this time, he contributed to the management of clinical trials, enhancing his expertise in the pharmaceutical sector and regulatory compliance.
Career at Acerta Pharma
Gonzales has a significant history with Acerta Pharma, a member of the AstraZeneca Group. He held various positions, including Clinical Trial Manager from 2015 to 2018 and Sr. Clinical Study Manager from 2018 to 2020. His tenure at Acerta Pharma provided him with comprehensive experience in clinical trial operations and regulatory compliance.
Background in Clinical Operations
Gonzales has extensive experience in clinical operations across multiple organizations. His career began at Cedars-Sinai, where he worked as an Operations Supervisor from 1998 to 2000. His journey through various roles in clinical research has equipped him with strong knowledge in clinical research coordinator activities and regulatory compliance.
Education and Expertise
Ruben Gonzales possesses a strong foundation in clinical research and regulatory compliance. His expertise is supported by years of experience in the pharmaceutical and healthcare industries, making him well-versed in the complexities of clinical trial management and operations.